论文部分内容阅读
目的研究益生菌对婴幼儿支气管肺炎治疗的影响。方法将120例婴幼儿支气管肺炎患儿进行随机分组,治疗组60例,对照组60例,两组均予以常规使用抗生素和对症治疗,治疗组在常规治疗基础上加服益生菌制剂,2个月~1岁患儿1片/次,3次/d,1~3岁患儿2片/次,3次/d。经治疗1周后,观察两组治疗结果。结果治疗组发热、咳嗽、气促等临床症状消失,肺部湿啰音消失和胸部X线阴影吸收的时间明显短于对照组(P<0.01);治疗组出现消化系统功能紊乱的情况比对照组显著降低;治疗组治愈率、总有效率均明显高于对照组(P<0.01);两组差异有统计学意义。结论益生菌在治疗婴幼儿支气管肺炎中起到很好的疗效,临床研究表明益生菌对婴幼儿支气管肺炎具有较好的辅助治疗作用,值得临床推广应用。
Objective To study the effect of probiotics on bronchial pneumonia in infants and young children. Methods 120 infants and children with bronchopneumonia were randomly divided into treatment group (60 cases) and control group (60 cases). Both groups were given routine antibiotics and symptomatic treatment. The treatment group received probiotics preparations on the basis of routine treatment, and two Month to 1 year old children 1 tablet / time, 3 times / d, 1 to 3 years old children 2 tablets / time, 3 times / d. After 1 week of treatment, the results of two groups were observed. Results The clinical symptoms such as fever, cough, shortness of breath disappeared in the treatment group, the disappearance of the pulmonary wet rales and the absorption of chest X-ray shadow were obviously shorter than those in the control group (P <0.01). The digestive system dysfunction in the treatment group was more obvious than that in the control group (P <0.01). The difference between the two groups was statistically significant. Conclusion Probiotics in the treatment of infantile bronchopneumonia play a very good curative effect, clinical studies have shown that probiotics on bronchopneumonia in infants with better adjuvant therapy, worthy of clinical application.